Hypha Laboratories Announces Completion of Phase 1 of Its State-of-the-Art Facility and Arrival of V5 Working MicroPearls(TM) Prototypes
Hypha Labs (OTCQB:FUNI) announces completion of Phase 1 of its Las Vegas Research and Production facility and arrival of V5 MicroPearls™ prototypes. The facility upgrades include a new sterile clean room, mixing lab, upgraded data networks, and prototyping equipment. The V5 MicroPearls™ features cloud-controlled microcontroller management for precise mushroom cultivation. These developments maintain the company's timeline for product sales rollout in Q4 2025. The facility enables expanded research on functional mushroom growth in eight-day cycles for home and commercial use.
Hypha Labs (OTCQB:FUNI) annuncia il completamento della Fase 1 della sua struttura di Ricerca e Produzione a Las Vegas e l'arrivo dei prototipi V5 MicroPearls™. Gli aggiornamenti della struttura includono una nuova sala sterile, un laboratorio di miscelazione, reti dati potenziate e attrezzature per il prototipaggio. Le V5 MicroPearls™ presentano una gestione dei microcontroller controllata da cloud per una coltivazione precisa dei funghi. Questi sviluppi mantengono la tempistica dell'azienda per il lancio delle vendite dei prodotti nel Q4 2025. La struttura permette una ricerca ampliata sulla crescita dei funghi funzionali in cicli di otto giorni per uso domestico e commerciale.
Hypha Labs (OTCQB:FUNI) anuncia la finalización de la Fase 1 de su instalación de Investigación y Producción en Las Vegas y la llegada de los prototipos V5 MicroPearls™. Las actualizaciones de la instalación incluyen una nueva sala estéril, un laboratorio de mezcla, redes de datos mejoradas y equipos de prototipado. Las V5 MicroPearls™ cuentan con gestión de microcontroladores controlada por la nube para un cultivo preciso de setas. Estos desarrollos mantienen el cronograma de la empresa para el lanzamiento de ventas de productos en el cuarto trimestre de 2025. La instalación permite una investigación ampliada sobre el crecimiento de hongos funcionales en ciclos de ocho días para uso doméstico y comercial.
Hypha Labs (OTCQB:FUNI)가 라스베이거스 연구 및 생산 시설의 1단계를 완료하고 V5 MicroPearls™ 프로토타입을 도착했다고 발표했습니다. 시설 업그레이드에는 새로운 무균 청정실, 혼합 실험실, 업그레이드된 데이터 네트워크, 프로토타이핑 장비가 포함됩니다. V5 MicroPearls™는 정밀한 버섯 재배를 위해 클라우드 기반의 마이크로컨트롤러 관리 기능을 제공합니다. 이러한 개발은 2025년 4분기의 제품 판매 출시 일정에 부합합니다. 이 시설은 가정 및 상업용으로 8일 주기로 기능성 버섯 성장에 대한 확장된 연구를 가능하게 합니다.
Hypha Labs (OTCQB:FUNI) annonce l'achèvement de la phase 1 de son installation de recherche et de production à Las Vegas et l'arrivée des prototypes V5 MicroPearls™. Les améliorations de l'installation comprennent une nouvelle salle propre stérile, un laboratoire de mélange, des réseaux de données améliorés et des équipements de prototypage. Les V5 MicroPearls™ disposent d'une gestion des microcontrôleurs contrôlée par cloud pour une culture précise des champignons. Ces développements respectent le calendrier de l'entreprise pour le lancement des ventes de produits au quatrième trimestre 2025. L'installation permet d'étendre la recherche sur la croissance des champignons fonctionnels en cycles de huit jours pour un usage domestique et commercial.
Hypha Labs (OTCQB:FUNI) gibt den Abschluss der Phase 1 seiner Forschungs- und Produktionsstätte in Las Vegas bekannt und die Ankunft der V5 MicroPearls™ Prototypen. Zu den Verbesserungen der Einrichtung gehören ein neuer steriler Reinraum, ein Mischlabor, verbesserte Datennetze und Prototyping-Ausrüstung. Die V5 MicroPearls™ verfügen über eine cloudgesteuerte Mikrocontroller-Verwaltung für eine präzise Pilzkultivierung. Diese Entwicklungen halten den Zeitplan des Unternehmens für den Verkaufsstart der Produkte im vierten Quartal 2025 ein. Die Einrichtung ermöglicht erweiterte Forschungen zum Wachstum funktioneller Pilze in acht-tägigen Zyklen für den privaten und kommerziellen Gebrauch.
- On track for product sales launch in Q4 2025
- Completed Phase 1 of Research and Production facility
- Upgraded facility with new clean room and mixing lab
- Advanced V5 MicroPearls™ prototype with cloud-controlled automation
- No current revenue generation
- Product launch still approximately one year away
Advancements Enhance Efficacy in Hypha's Revolutionary Home and Commercial Production Units
LAS VEGAS, NV / ACCESSWIRE / November 18, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce it has completed Phase 1 of construction and design for its Research and Production facility in Las Vegas, Nevada as well as the arrival of its V5 MicroPearls™ prototype.
Completion of Phase 1 at the facility is significant for a multitude of reasons, not least of which is it maintains the Company's anticipated timeline to begin roll-out of product sales in the fourth quarter of 2025. Secondly, the new facility allows the Company to expand and build upon its groundbreaking research which gives individuals the power to grow a broad array of functional mushrooms from the comfort and privacy of home in a predictable eight-day cycle.
"These are not just milestones for Hypha Labs, but catalytic to our progress," stated Stone Douglass, CEO, Hypha Labs, Inc. "We are moving at an accelerated pace now into one of the most lucrative categories in functional mushrooms with what we believe is a truly unique, market disruptive product offering."
The advancements at the facility and in the V5 MicroPearls™ are significant:
Facility Improvements and Additions
Hypha Labs is pleased to have completed initial construction stages and now have newly upgraded workspaces with the following improvements:
* A new sterile clean room in the Las Vegas lab to accelerate our genetic experimentation work at Hyphalabs.
* Brand new mixing lab/kitchen for larger scale inventory management and personal.
* Newly upgraded data networks and communication equipment for the lab and offices, which allowed for more applied analysis and increases the efficacy of our Artificial Intelligence (AI) systems.
* Conference room upgrades to host meetings and large data screens for information sharing or other collaborative efforts.
* Prototyping equipment now online and built-out in our mechanical/electronic lab. This makes us far more agile in our modification and enhancement efforts.
The Arrival of Version 5 MicroPearls™ Mushroom AcceleratorPrototypes
A new fleet of Version 5 MicroPearls™ prototypes has been delivered. V5 brings with it fully operational cloud-controlled microcontroller management in each bioreactor. This allows for consistent environmental profile control, motor controls, aeration controls, and more, all of which are now fully controlled and automated. The result is a more precise mushroom ingredient harvest for the home or commerical operator.
New Test Plans
New test plans will now be executed at a much higher rate, with more strains tested both at our internal Las Vegas facility and, thanks to our new video/data network, in collaboration with outside consultants.
About Hypha Labs, Inc.
The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at HyphaLabs.com.
SAFE HARBOR FORWARD LOOKING STATEMENTS:
This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.
From time to time, the Company may post new and material information on its website or through its social media profiles at the links below:
LN: https://www.linkedin.com/company/hypha-labs-inc/
FB: https://www.facebook.com/hyphalabs
IG: https://www.instagram.com/hyphalabsinc/
Twitter: https://x.com/Hypha_Labs
For more information about Hypha Labs visit HyphaLabs.com
For the Company's current Investor Presentation please visit www.HyphaLabs.com/deck
Investor and Media Relations:
Integrity MediaInc.
(888) 216-3595
team@integritymedia.com
Contact Information
Kurt Divich
President, Integrity Media Inc.
team@integritymedia.com
(888) 216-3595
SOURCE: Hypha Labs, Inc.
View the original press release on accesswire.com
FAQ
When will Hypha Labs (FUNI) begin product sales?
What improvements were made in Hypha Labs' (FUNI) Phase 1 facility completion?
What are the new features of Hypha Labs' (FUNI) V5 MicroPearls™ prototypes?
